Predictive Models May Reduce False-Positive Results of Breast Cancer Screening
Both models would have reduced false positives without missing any cancer cases.
Cancer
Low-Intensity Focused Ultrasound May Safely, Effectively Treat Chemo-Induced Peripheral Neuropathy
The researchers’ goal was to evaluate the effectiveness of low-intensity focused ultrasound (LIFU) therapy in the management of cancer-related neuropathic pain (CNP).
Women’s Cancer Screenings Plummeted During Pandemic
Breast and cervical cancer screenings dropped sharply among low-income minority women during the COVID-19 pandemic.
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
More than one-third of adolescent and young adult (AYA) cancer survivors report COVID-19 vaccine hesitancy.
IV Ketamine Shown to Be Effective and Safe for Cancer-Related Neuropathic Pain
The researchers’ goal was to evaluate the safety and effectiveness of an intravenous ketamine protocol to treat refractory CNP and uncover synergies between ketamine and common neuropathy treatments.
Four Factors That Promote Shared Understanding Between Nurses and Physicians in Oncology Care Units
An analysis of 33 video-recorded conversations helped to identify factors that lead to effective communication in oncology care settings.
How Intermittent Fasting Affects Patients Receiving Tyrosine Kinase Inhibitors for CML
Researchers sought to determine the effects of fasting on drug absorption and efficacy in patients receiving TKIs for chronic myeloid leukemia.
COVID-19 Lockdown: Melanomas Still Diagnosed but Follow-Up Decreased
Italian researchers retrospectively compared dermatologic and surgical activity in their melanoma unit from February to May, 2020, with data from the same period in 2019.
Immunogenicity and Safety of the Pfizer-BioNTech COVID-19 Vaccine in Patients With Cancer
This study evaluated the efficacy of the BNT162b2 vaccine in patients with solid tumors or hematologic cancers compared with healthy participants.
Pandemic Caused Cancer Screening Deficits in 2020
Results of a retrospective cohort study shows the impact of COVID-19 pandemic on screening rates for breast, prostate, and colorectal cancer.
- Loading...
Loading...
Next post in Practice Management
Loading... 
Loading...